Dr CK Narayan of Chart Advise has a sell call on Ajanta Pharma Ltd.

with a target price of Rs 1040.

The current market price of Ajanta Pharma Ltd.

is Rs 1047.1.

Time period given by the analyst is Intra Day when Ajanta Pharma Ltd.

price can reach the defined target.

Dr CK Narayan recommended to keep stoploss at Rs 1065.

Ajanta Pharma Ltd., incorporated in 1979, is a midcap company with a market cap of Rs 9216.89 crore. Ajanta Pharma Ltd.

key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 1762.69 Crore to Sales Value (96.29 % of Total Sales), Export Incentives which contributed Rs 66.17 Crore to Sales Value (3.61 % of Total Sales) and Other Operating Revenue which contributed Rs 1.59 Crore to Sales Value (0.08 % of Total Sales)for the year ending 31-Mar-2018.

For the quarter ended 30-09-2018, the company has reported a Consolidated sales of Rs 544.11 Crore, up 6.48 % from last quarter Sales of Rs 510.99 Crore and up .69 % from last year same quarter Sales of Rs 540.38 Crore Company has reported net profit after tax of Rs 125.39 Crore in latest quarter.

The company’s top management includes Dr.Anil Kumar, Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar R Dalal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal.

Company has B S R Co.

LLP as its auditoRs As on 30-09-2018, the company has a total of 88,023,000 shares outstanding.